Funded Startups in Shenzhen
Disclosed deal sizes in Shenzhen are concentrated in a lower-to-mid range, while the largest rounds stand out sharply: PaXini Tech ($148M, 2026-08-03) and…
Disclosed deal sizes in Shenzhen are concentrated in a lower-to-mid range, while the largest rounds stand out sharply: PaXini Tech ($148M, 2026-08-03) and Futuring Robot ($148M, 2026-07-22) dwarf the next-largest disclosed round ($140M by X Square on 2025-09-11), and both are well above the $52M Neptune Robotics round (2025-10-02). At the other end, the smallest disclosed amount is Salus BioMed’s $7M (2025-10-12), making the disclosed spread from $7M to $148M.
Timing and concentration also look uneven. Rounds span 2025-09-09 to 2026-08-05, with 2026 accounting for 10 of the 42 rows; the most recent disclosed entries include PaXini Tech on 2026-08-03 ($148M) and Futuring Robot on 2026-07-22 ($148M). Stage labeling is broad across Series A (13), Series B (10), and Seed (9), with Robotics and AI appearing frequently (both 8) among the recurring Shenzhen-based companies.
Most recent rounds
42 shownRelated listings
Frequently asked
Which disclosed rounds are the clear size outliers in Shenzhen, and what do they imply for deal-size expectations?
The disclosed leader is a tie at $148M: PaXini Tech (2026-08-03) and Futuring Robot (2026-07-22). The next-largest disclosed amount is $140M from X Square (2025-09-11), while the smallest disclosed deal is $7M from Salus BioMed (2025-10-12).
Do the largest disclosed rounds cluster within a narrow time window, or are they spread across the period shown?
The top disclosed amounts appear in two different time pockets: $148M rounds in July–August 2026 (Futuring Robot on 2026-07-22; PaXini Tech on 2026-08-03) and the $140M X Square round in September 2025 (2025-09-11). The next-largest after that is $52M for Neptune Robotics in October 2025 (2025-10-02), indicating the $50M+ band is not confined to a single quarter.
What fraction of rounds are disclosed vs. undisclosed, and does the disclosed range suggest broad visibility gaps?
Out of 42 rows, 12 disclosed rounds and 30 undisclosed rounds are shown. Disclosed amounts run from $7M (Salus BioMed, 2025-10-12) up to $148M (PaXini Tech, 2026-08-03; Futuring Robot, 2026-07-22), but the majority of entries provide no amount.
Is there a stage mix pattern across Shenzhen, and where do the biggest disclosed deals land by stage label?
Stage labels are distributed across Series A (13), Series B (10), Seed (9), Series C (5), Series Unknown (2), and Venture - Series Unknown (2). The biggest disclosed deals include Series C for PaXini Tech ($148M, 2026-08-03) and Seed for Futuring Robot ($148M, 2026-07-22), while X Square’s $140M (2025-09-11) is labeled Series A.
Are specific sectors over-represented in this Shenzhen set, based on repeated category frequency?
Robotics (8) and Artificial Intelligence (AI) (8) are the most repeated sectors in the list, alongside Manufacturing (8). Electronics (6) and Biotechnology (6) also recur, which helps explain why high-value rounds show up across robotics/AI-adjacent companies like Futuring Robot ($148M, 2026-07-22) and X Square ($140M, 2025-09-11).
Which entries are worth an analyst’s closer look near the ends of the disclosed spectrum?
On the low end, Salus BioMed’s $7M round (2025-10-12) is the smallest disclosed amount shown. On the high end, the $148M outliers (PaXini Tech on 2026-08-03 and Futuring Robot on 2026-07-22) sit far above the next-largest disclosed amount at $140M (X Square, 2025-09-11).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.